Search
01/01/2026
Sex differences in neurocognitive response to metacognitive training in first-episode psychosis: Implications for personalized interventions
Verdaguer-Rodríguez, M., Comas, J.O., López-Carrilero, R., Díaz-Cutraro, L., Espinosa, V., Ruiz-Delgado, I., Barrigón, M.L., Grasa, E., Pousa, E., González-Higueras, F., Cid, J., Lorente-Rovira, E., Barajas, A., Ochoa, S.. Sex differences in neurocognitive response to metacognitive training in first-episode psychosis: Implications for personalized interventions. Archives of Womens Mental Health. 2026; 29(1)DOI:10.1007/s00737-025-01637-3. PMID:41661387. IF:2.700(Q2/4D).
01/12/2025
Combining Life History Calendars and Ecological Momentary Assessment for Evaluating Everyday Stress and Its Impact on Mental Health in Healthy Adults: Longitudinal Study
Chavarría-Elizondo, P, Tortella-Feliu, M, Fortea, L, De la Peña-arteaga, V, Juaneda-Seguí, A, Martínez-Zalacaín, I, Vilajosana, E, Radua, J, Shackman, AJ, Soriano-Mas, C, Fullana, MA. Combining Life History Calendars and Ecological Momentary Assessment for Evaluating Everyday Stress and Its Impact on Mental Health in Healthy Adults: Longitudinal Study. STRESS AND HEALTH. 2025; 41(6)DOI:10.1002/smi.70128. PMID:41307189. IF:2.700(Q2/4D).
01/09/2025
Impact of Relapse in BDNF Receptors Expression in Patients With a First Episode of Schizophrenia
Bioque, M, Llorca-Bofi, V, MacDowell, KS, Amoretti, S, Mezquida, G, Cuesta, MJ, Diaz-Caneja, CM, Ibáñez, A, Segarra, R, González-Pinto, A, Roldán, A, Sáiz, PA, Mané, A, Lobo, A, Martínez-Pinteño, A, Cano-Escalera, G, Berrocoso, E, Bernardo, M. Impact of Relapse in BDNF Receptors Expression in Patients With a First Episode of Schizophrenia. SCHIZOPHRENIA BULLETIN. 2025; 51(5)DOI:10.1093/schbul/sbaf012. PMID:39977257. IF:4.800(Q1/2D).
23/08/2025
Neural correlates of human fear conditioning and sources of variability in 2199 individuals
Radua, J, Savage, HS, Vilajosana, E, Jamieson, A, Abler, B, Åhs, F, Beckers, T, Cardoner, N, Cisler, JM, Diniz, JB, Bach, DR, Elsenbruch, S, Greening, SG, Holt, DJ, Kaczkurkin, AN, Keil, A, Kindt, M, Koch, K, LaBar, KS, Lam, CL, Larson, CL, Lonsdorf, TB, Merz, CJ, McLaughlin, KA, Neria, Y, Pine, DS, van Reekum, CM, Shackman, AJ, Soriano-Mas, C, Spoormaker, VI, Stout, DM, Straube, B, Straube, T, Tuominen, L, Visser, RM, Ahumada, L, Arolt, V, Batistuzzo, MC, Bazán, PR, Biggs, EE, Cano, M, Chavarría-Elizondo, P, Cooper, SE, Dannlowski, U, de la Peña-arteaga, V, Decross, SN, Domschke, K, Ehlers, MR, Graner, JL, Hamm, AO, Herrmann, MJ, Huggins, AA, Icenhour, A, Juaneda-Seguí, A, Junghoefer, M, Kircher, T, Koelkebeck, K, Kuhn, M, Labrenz, F, Lissek, SM, Lotze, M, Lueken, U, Margraf, J, Martínez-Zalacaín, I, Moeck, R, Morriss, J, Ortuño, M, Pittig, A, Porta-Casteras, D, Richter, J, Ridderbusch, IC, Rief, W, Roesmann, K, Rosén, J, Russmann, AN, Sjouwerman, R, Spohrs, J, Ströhle, A, Suarez-Jimenez, B, Ulrich, M, Wittchen, HU, Zhu, X, Waller, L, Walter, H, Thompson, PM, Bas-Hoogendam, JM, Groenewold, NA, Stein, DJ, van der Wee, NJ, Dunsmoor, JE, Marquand, AF, Harrison, BJ, Fullana, MA. Neural correlates of human fear conditioning and sources of variability in 2199 individuals. Nature Communications. 2025; 16(1)DOI:10.1038/s41467-025-63078-x. PMID:40849409. IF:15.700(Q1/1D).
19/08/2025
Mapping cross-modal functional connectivity of major neurotransmitter systems in the human brain
Saiz-Masvidal, C, De la Peña-Arteaga, V, Bertolín, S, Diez, I, Juaneda-Seguí, A, Martínez-Zalacaín, I, Chavarría-Elizondo, P, Subirà, M, Menchón, JM, Sepulcre, J, Fullana, MA, Soriano-Mas, C. Mapping cross-modal functional connectivity of major neurotransmitter systems in the human brain. Brain Structure & Function. 2025; 230(7)DOI:10.1007/s00429-025-02996-4. PMID:40828212. IF:2.900(Q1/1D).
01/08/2025
Effectiveness of a Post-discharge Phone-Based Smoking Cessation Intervention for Patients with Severe Mental Health Disorders: The 061 Quitmental Randomized Controlled Clinical Trial
Martinez, C, Feliu, A, Saura, J, Nieva, G, Pinet, C, Raich, A, Mondon, S, Barrio, P, Andreu, M, Hernández-Ribas, R, Costa, S, Suelves, JM, Vilaplana, J, Enriquez, M, Alaustre, L, Vilalta, E, Alvarez, JB, Guydish, J, Fernández, E, Ballbè, M. Effectiveness of a Post-discharge Phone-Based Smoking Cessation Intervention for Patients with Severe Mental Health Disorders: The 061 Quitmental Randomized Controlled Clinical Trial. International Journal of Mental Health and Addiction. 2025; 23(4)DOI:10.1007/s11469-024-01254-8. PMID:40936741. IF:2.500(Q2/4D).
01/03/2025
Interrelationships between polygenic risk scores, cognition, symptoms, and functioning in first-episode psychosis: A network analysis approach
Gil-Berrozpe, GJ, Segura, AG, Sánchez-Torres, AM, Amoretti, S, Giné-Servén, E, Vieta, E, Mezquida, G, Lobo, A, Gonzalez-Pinto, A, Andreu-Bernabeu, A, Roldán, A, Forte, MF, Castro, J, Bergé, D, Rodríguez, N, Ballesteros, A, Mas, S, Cuesta, MJ, Bernardo, M. Interrelationships between polygenic risk scores, cognition, symptoms, and functioning in first-episode psychosis: A network analysis approach. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2025; 92DOI:10.1016/j.euroneuro.2024.12.002. PMID:39721378. IF:6.700(Q1/1D).
01/02/2025
Efficacy of esketamine nasal spray over quetiapine extended release over the short and long term: sensitivity analyses of ESCAPE-TRD, a randomised phase IIIb clinical trial
Young, AH, Llorca, PM, Fagiolini, A, Falkai, P, Cardoner, N, Nielsen, RE, Blomqvist, O, Godinov, Y, Rive, B, Diels, J, Mulhern-Haughey, S, Reif, A. Efficacy of esketamine nasal spray over quetiapine extended release over the short and long term: sensitivity analyses of ESCAPE-TRD, a randomised phase IIIb clinical trial. BRITISH JOURNAL OF PSYCHIATRY. 2025; 226(2)DOI:10.1192/bjp.2024.124. PMID:39618237. IF:7.600(Q1/1D).
01/03/2022
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum
Jansen, WJ, Janssen, O, Tijms, BM, Vos, SJB, Ossenkoppele, R, Visser, PJ, Alcolea D., Amyloid Biomarker Study Grp. Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum. JAMA Neurology. 2022; 79(3)DOI:10.1001/jamaneurol.2021.5216. PMID:35099509. IF:29.000(Q1/1D).
04/10/2023
Multivariate GWAS of Alzheimer's disease CSF biomarker profiles implies GRIN2D in synaptic functioning.
Neumann A, Ohlei O, Küçükali F, Bos IJ, Timsina J, Vos S, Prokopenko D, Tijms BM, Andreasson U, Blennow K, Vandenberghe R, Scheltens P, Teunissen CE, Engelborghs S, Frisoni GB, Blin O, Richardson JC, Bordet R, Lleó A, Alcolea D, Popp J, Marsh TW, Gorijala P, Clark C, Peyratout G, Martinez-Lage P, Tainta M, Dobson RJB, Legido-Quigley C, Van Broeckhoven C, Tanzi RE, Ten Kate M, Lill CM, Barkhof F, Cruchaga C, Lovestone S, Streffer J, Zetterberg H, Visser PJ, Sleegers K, Bertram L. Multivariate GWAS of Alzheimer's disease CSF biomarker profiles implies GRIN2D in synaptic functioning.. Genome Medicine. 2023; 15(1)DOI:10.1186/s13073-023-01233-z. PMID:37794492. IF:10.400(Q1/1D).
19/09/2023
Brain hypometabolism in non-demented microtubule-associated protein tau H1 carriers with Parkinson's disease.
Gasca-Salas C, Trompeta C, López-Aguirre M, Rodríguez Rojas R, Clarimon J, Dols-Icardo O, El Bounasri S, Guida P, Mata-Marín D, Hernández-Fernández F, Marras C, García-Cañamaque L, Plaza de Las Heras I, Obeso I, Vela L, Fernández-Rodríguez B. Brain hypometabolism in non-demented microtubule-associated protein tau H1 carriers with Parkinson's disease.. JOURNAL OF NEUROIMAGING. 2023; 33(6)DOI:10.1111/jon.13156. PMID:37726927. IF:2.300(Q2/5D).
13/09/2023
CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer´s disease.
Del Campo M, Vermunt L, Peeters CFW, Sieben A, Hok-A-Hin YS, Lleó A, Alcolea D, van Nee M, Engelborghs S, van Alphen JL, Arezoumandan S, Chen-Plotkin A, Irwin DJ, van der Flier WM, Lemstra AW, Teunissen CE. CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer´s disease.. Nature Communications. 2023; 14(1)DOI:10.1038/s41467-023-41122-y. PMID:37704597. IF:14.700(Q1/1D).
17/08/2023
Brain connectivity correlates of cognitive dispersion in a healthy middle-aged population: influence of subjective cognitive complaints.
Mulet-Pons L, Solé-Padullés C, Cabello-Toscano M, Abellaneda-Pérez K, Perellón-Alfonso R, Cattaneo G, Solana Sánchez J, Alviarez-Schulze V, Bargalló N, Tormos-Muñoz JM, Pascual-Leone A, Bartrés-Faz D, Vaqué-Alcázar L. Brain connectivity correlates of cognitive dispersion in a healthy middle-aged population: influence of subjective cognitive complaints.. JOURNALS OF GERONTOLOGY SERIES B-PSYCHOLOGICAL SCIENCES AND SOCIAL SCIENCES. 2023; 78(11)DOI:10.1093/geronb/gbad114. PMID:37587033. IF:4.800(Q1/1D).
01/06/2025
On the complexity of biomarker-driven diagnoses of Alzheimer's disease
Grasso, SM, Santos-Santos, MA, Clark, AL. On the complexity of biomarker-driven diagnoses of Alzheimer's disease. Journal of Neuropsychology. 2025; 19(2)DOI:10.1111/jnp.12428. PMID:40317662. IF:1.800(Q3/6D).
24/03/2025
Potential of facial biomarkers for Alzheimer's disease and obstructive sleep apnea in Down syndrome and general population
Echeverry-Quiceno, LM, Llambrich, S, Heredia-Lidón, A, Giménez, S, Rozalem-Aranha, M, Inampudi, P, Heuzé, Y, Sevillano, X, Fortea, J, Martinez-Abadias, N, Alzheimers Dis Neuroimaging Initiative. Potential of facial biomarkers for Alzheimer's disease and obstructive sleep apnea in Down syndrome and general population. FASEB JOURNAL. 2025; 39(6)DOI:10.1096/fj.202403009R. PMID:40123509. IF:4.200(Q1/2D).
01/03/2026
Potential role of MRI to optimize clinical trial design for progressive supranuclear palsy and corticobasal degeneration
Garcia-Castro, J, Vandevrede, L, Donohue, MC, Vaqué-Alcázar, L, Rubio-Guerra, S, Selma-González, J, Heuer, HW, Morcillo-Nieto, AO, Franquesa, M, Dols-Icardo, O, Bejanin, A, Belbin, O, Fortea, J, Alcolea, D, Carmona-Iragui, M, Abdelnour, C, Barroeta, I, Santos-Santos, M, Saudinós, MBS, Sala, I, Lleó, A, Gorno-Tempini, ML, Mandelli, ML, Raman, R, Wills, AM, Barragan, E, Litvan, I, Boeve, B, Dickerson, B, Grossman, M, Huey, ED, Irwin, DJ, Pantelyat, A, Tartaglia, C, Rojas, JC, Boxer, AL, Illán-Gala, I. Potential role of MRI to optimize clinical trial design for progressive supranuclear palsy and corticobasal degeneration. JPAD-Journal of Prevention of Alzheimers Disease. 2026; 13(3)DOI:10.1016/j.tjpad.2026.100486. PMID:41581260. IF:7.800(Q1/1D).
01/02/2026
Lessons from the Colombian kindred: rethinking Alzheimer's prevention
Fortea, J, Llibre-Guerra, J, O'Connor, A, Levin, J. Lessons from the Colombian kindred: rethinking Alzheimer's prevention. LANCET NEUROLOGY. 2026; 25(2)DOI:10.1016/S1474-4422(25)00481-8. PMID:41579884. IF:45.500(Q1/1D).
01/01/2026
Cerebrospinal Fluid Fatty Acids, Hypothalamic Inflammation, and Weight Loss in Human Obesity: A Longitudinal Study
Pané, A, Videla, L, Calvet-Mirabent, A, Castro-Barquero, S, Viaplana, J, Vaqué-Alcázar, L, Ibarzabal, A, Rozalem-Aranha, M, Bejanin, A, Moize, V, Vidal, J, De Hollanda, A, Ortega, E, Barroeta, I, Camacho, V, Chiva-Blanch, G, Fortea, J, Jiménez, A. Cerebrospinal Fluid Fatty Acids, Hypothalamic Inflammation, and Weight Loss in Human Obesity: A Longitudinal Study. DIABETES. 2026; 75(1)DOI:10.2337/db25-0595. PMID:41247745. IF:7.500(Q1/1D).
01/01/2026
Exploiting Generative Models for Downstream Classification Tasks on Latent Spaces Using 3D Brain MRI Scans: A Down Syndrome Case Study
Malé, J, Fortea, J, Rozalem-Aranha, M, Martínez-Abadías, N, Sevillano, X. Exploiting Generative Models for Downstream Classification Tasks on Latent Spaces Using 3D Brain MRI Scans: A Down Syndrome Case Study. Pattern Recognition And Image Analysis, Ibpria 2025, Pt Ii. 2026; 15938DOI:10.1007/978-3-031-99568-2_11. PMID:. IF:(Q/D).
12/12/2025
Clinical recognition of frontotemporal dementia with right temporal predominance: a consensus statement from the International Working Group
Ulugut, H, Younes, K, Montembeault, M, Bertoux, M, Irish, M, Kumfor, F, Fumagalli, GG, Samanci, B, Illán-Gala, I, Thompson, JC, Santillo, AF, Englund, E, Waldö, ML, Riedl, L, van den Stock, J, Vandenbulcke, M, Vandenberghe, R, Laforce, R, Ducharme, S, Pressman, PS, Caramelli, P, de Souza, LC, Takada, LT, Gurvit, H, Diehl-Schmid, J, Galimberti, D, Pasquier, F, Weintraub, S, Miller, BL, Sturm, VE, Whitwell, JL, Boeve, B, Rohrer, JD, Piguet, O, Gorno-Tempini, ML, Josephs, KA, Snowden, J, Rowe, JB, Warren, JD, Rankin, KP, Pijnenburg, YAL. Clinical recognition of frontotemporal dementia with right temporal predominance: a consensus statement from the International Working Group. Communications Medicine. 2025; 5(1)DOI:10.1038/s43856-025-01252-4. PMID:41387629. IF:(Q/D).